Home
About Us
Who We Are
Our Niche
Our Results
Recent Placements
Replacement Policy
Our Brochures
Our Team
Hot Jobs
Search Services
Search Services
Diversity & Inclusion
Code of Ethics
Awards & Recognitions
Career Coaching
Resources
Recruiter Tips
News and Insights
Resume Resources
Working From Home
My Inspirement
Healthy Living for Executives
Testimonials
AI Training and Quality Disclosure
Contact Us

The Bandish Group

Home
About Us
Who We Are
Our Niche
Our Results
Recent Placements
Replacement Policy
Our Brochures
Our Team
Hot Jobs
Search Services
Search Services
Diversity & Inclusion
Code of Ethics
Awards & Recognitions
Career Coaching
Resources
Recruiter Tips
News and Insights
Resume Resources
Working From Home
My Inspirement
Healthy Living for Executives
Testimonials
AI Training and Quality Disclosure
Contact Us
Jackie Bandish
November 2, 2021

AstraZeneca enters a $270 million deal with Covis

Jackie Bandish
November 2, 2021

As AstraZeneca continues to focus on newer medicines, they have announced that they will sell its global rights to COPD inhalers Tudorza and Duaklir to Covis Pharma. The deal is expected to close by the end of the year at a cost of $270 million.

Click here to learn more about the deal.

Newer PostBluebird bio has a New Headquarter Location
Older PostFierce Pharma ranks the top 10 drug launch disasters in the past five years
Back to Top
Home
About Us
Who We Are
Our Niche
Our Results
Recent Placements
Replacement Policy
Our Brochures
Our Team
Hot Jobs
Search Services
Search Services
Diversity & Inclusion
Code of Ethics
Awards & Recognitions
Career Coaching
Resources
Recruiter Tips
News and Insights
Resume Resources
Working From Home
My Inspirement
Healthy Living for Executives
Testimonials
AI Training and Quality Disclosure
Contact Us
The Bandish Group, LLC, Bucks County, PA267-483-5233info@bandishgroup.com

Headquarters: Greater Philadelphia Area